Amedisys Inc (AMED)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 67,780 127,537 112,037 -539 10,307 2,648 2,330 112,184 118,609 120,939 140,303 190,873 209,072 220,176 247,151 201,676 183,608 166,112 128,263 127,331
Total assets US$ in thousands 2,138,710 2,139,110 2,117,370 2,089,870 2,060,170 2,027,420 1,982,400 1,946,960 1,976,240 1,982,130 2,000,990 1,908,390 1,856,970 1,937,640 1,599,560 1,573,210 1,567,200 1,602,720 1,645,490 1,440,080
ROA 3.17% 5.96% 5.29% -0.03% 0.50% 0.13% 0.12% 5.76% 6.00% 6.10% 7.01% 10.00% 11.26% 11.36% 15.45% 12.82% 11.72% 10.36% 7.79% 8.84%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $67,780K ÷ $2,138,710K
= 3.17%

Amedisys Inc's return on assets (ROA) has experienced fluctuations over the period from March 31, 2020, to December 31, 2024. The ROA started at 8.84% in March 2020, decreased slightly to 7.79% in June 2020, but then showed an upward trend, reaching a peak of 15.45% in June 2021. Subsequently, there was a decline in ROA to 6.10% by September 2022 and further down to 0.12% by June 2023, before slightly recovering to 5.96% by September 2024.

Overall, Amedisys Inc's ROA has shown variability, with some periods of strong performance followed by periods of decline. The downward trend in ROA in recent quarters may indicate challenges in generating profits relative to the company's total assets. It is important for stakeholders to monitor these fluctuations and assess the factors driving changes in the company's ROA to make informed decisions.